Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
HTRA1
Introduction
Serine protease HTRA1 is an enzyme that in humans is encoded by the HTRA1 gene.[1][2] The HTRA1 protein is composed of four distinct protein domains. They are from amino-terminus to carboxyl-terminus an Insulin-like growth factor binding domain, a kazal domain, a trypsin-like peptidase domain and a PDZ domain.
This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth.[2]
Mutations of this gene are responsible for the development of CARASIL, a genetic form of cerebral vasculopathy.
References
References
- ↑ Zumbrunn J, Trueb B (Jan 1997). “Primary structure of a putative serine protease specific for IGF-binding proteins”. FEBS Lett. 398 (2–3): 187–92. doi:10.1016/S0014-5793(96)01229-X. PMID 8977104.
- ↑ 2.0 2.1 “Entrez Gene: HTRA1 HtrA serine peptidase 1”.
External links
External links
Further reading
Further reading
- Bradley, D T; Zipfel, P F; Hughes, A E (2011). “Complement in age-related macular degeneration: a focus on function”. Eye. 25 (6). doi:10.1038/eye.2011.37. PMCÂ 3178140. PMIDÂ 21394116.
- Zurawa-Janicka D, Narkiewicz J, LipiÅ„ska B (2007). “[Characterization of the HtrA family of proteins]”. Postepy Biochem. 53 (1): 27–36. PMID 17718385.
- Andersson B, Wentland MA, Ricafrente JY, et al. (1996). “A “double adaptor” method for improved shotgun library construction”. Anal. Biochem. 236 (1): 107–13. doi:10.1006/abio.1996.0138. PMID 8619474.
- Yu W, Andersson B, Worley KC, et al. (1997). “Large-scale concatenation cDNA sequencing”. Genome Res. 7 (4): 353–8. doi:10.1101/gr.7.4.353. PMC 139146. PMID 9110174.
- Zumbrunn J, Trueb B (1998). “Localization of the gene for a serine protease with IGF-binding domain (PRSS11) to human chromosome 10q25.3-q26.2”. Genomics. 45 (2): 461–2. doi:10.1006/geno.1997.4953. PMID 9344681.
- Hu SI, Carozza M, Klein M, et al. (1999). “Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage”. J. Biol. Chem. 273 (51): 34406–12. doi:10.1074/jbc.273.51.34406. PMID 9852107.
- Baldi A, De Luca A, Morini M, et al. (2002). “The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells”. Oncogene. 21 (43): 6684–8. doi:10.1038/sj.onc.1205911. PMID 12242667.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Nie GY, Hampton A, Li Y, et al. (2003). “Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2”. Biochem. J. 371 (Pt 1): 39–48. doi:10.1042/BJ20021569. PMC 1223265. PMID 12513693.
- De Luca A, De Falco M, Severino A, et al. (2003). “Distribution of the serine protease HtrA1 in normal human tissues”. J. Histochem. Cytochem. 51 (10): 1279–84. doi:10.1177/002215540305101004. PMID 14500695.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Chien J, Staub J, Hu SI, et al. (2004). “A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer”. Oncogene. 23 (8): 1636–44. doi:10.1038/sj.onc.1207271. PMID 14716297.
- Oka C, Tsujimoto R, Kajikawa M, et al. (2004). “HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins”. Development. 131 (5): 1041–53. doi:10.1242/dev.00999. PMID 14973287.
- Colland F, Jacq X, Trouplin V, et al. (2004). “Functional proteomics mapping of a human signaling pathway”. Genome Res. 14 (7): 1324–32. doi:10.1101/gr.2334104. PMC 442148. PMID 15231748.
- Grau S, Baldi A, Bussani R, et al. (2005). “Implications of the serine protease HtrA1 in amyloid precursor protein processing”. Proc. Natl. Acad. Sci. U.S.A. 102 (17): 6021–6. doi:10.1073/pnas.0501823102. PMC 1087941. PMID 15855271.
- Ozturk A, Desai PP, Minster RL, et al. (2005). “Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer’s disease”. Neurobiol. Aging. 26 (8): 1161–5. doi:10.1016/j.neurobiolaging.2004.11.001. PMID 15917099.
- Grau S, Richards PJ, Kerr B, et al. (2006). “The role of human HtrA1 in arthritic disease”. J. Biol. Chem. 281 (10): 6124–9. doi:10.1074/jbc.M500361200. PMID 16377621.
- Bowden MA, Di Nezza-Cossens LA, Jobling T, et al. (2006). “Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer”. Gynecol. Oncol. 103 (1): 253–60. doi:10.1016/j.ygyno.2006.03.006. PMID 16650464.
- Chien J, Aletti G, Baldi A, et al. (2006). “Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity”. J. Clin. Invest. 116 (7): 1994–2004. doi:10.1172/JCI27698. PMC 1474818. PMID 16767218.
- Dewan A, Liu M, Hartman S, et al. (2006). “HTRA1 promoter polymorphism in wet age-related macular degeneration”. Science. 314 (5801): 989–92. doi:10.1126/science.1133807. PMID 17053108.